Regencell Bioscience (RGC) stock slid 8% into the New Year’s Day market shutdown — what’s next
Regencell Bioscience Holdings shares fell 8.3% to $21 on Dec. 31, closing at session lows with below-average volume before the New Year’s Day market holiday. No new company news has been posted since Oct. 31. The stock’s 52-week range spans $0.09 to $83.60. Regencell’s market value stands near $10.4 billion.
